CD4 and neoplasm: On one hand, in murine models, antibiotic treatment targeting the gut microbiota alters the immune phenotype of TME, inducing activation of anti-tumor T cells to restrain tumor growth (32), evidenced by enhanced differentiation of CD4+ T cells into helper T cell 1 (Th1) and heightened activity of CD8+ T cells (33).